The department said Aug. 19 the drugmaker violated the Federal Food, Drug, and Cosmetic Act by “failing to have adequate procedures to prevent cross-contamination of equipment, failing to reject drug lots using a contaminated ingredient and failing to fully investigate the root cause of such contamination.”
The FDA inspected the facility in 2011, 2014, 2016, 2019 and 2021. In 2017, the agency issued a warning letter.
Morton Grove Pharmaceuticals will stop producing, labeling and distributing its “adulterated drugs,” according to the Justice Department. The company must also destroy all drugs in the facility except for medically necessary products.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
